631 related articles for article (PubMed ID: 17188885)
1. A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma.
Lucchi M; Chella A; Melfi F; Dini P; Ambrogi M; Fino L; Fontanini G; Mussi A
Eur J Cardiothorac Surg; 2007 Mar; 31(3):529-33; discussion 533-4. PubMed ID: 17188885
[TBL] [Abstract][Full Text] [Related]
2. A phase II study of intrapleural immunochemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy, and long-term subcutaneous IL-2 in stage II-III malignant pleural mesothelioma.
Rusch VW
Eur J Cardiothorac Surg; 2007 Mar; 31(3):534-5. PubMed ID: 17267238
[No Abstract] [Full Text] [Related]
3. Multimodality treatment of malignant pleural mesothelioma with or without immunotherapy: does it change anything?
Lucchi M; Picchi A; Alí G; Chella A; Guglielmi G; Cristaudo A; Fontanini G; Mussi A
Interact Cardiovasc Thorac Surg; 2010 Apr; 10(4):572-6. PubMed ID: 20053697
[TBL] [Abstract][Full Text] [Related]
4. Thoracic stop-flow perfusion in the treatment of refractory malignant pleural mesothelioma: a phase I-II evaluation/trial.
Guadagni S; Clementi M; Valenti M; Fiorentini G; Cantore M; Kanavos E; Amicucci G
In Vivo; 2006; 20(6A):715-8. PubMed ID: 17203752
[TBL] [Abstract][Full Text] [Related]
5. Four-modality therapy in malignant pleural mesothelioma: a phase II study.
Lucchi M; Chella A; Melfi F; Dini P; Tibaldi C; Fontanini G; Mussi A
J Thorac Oncol; 2007 Mar; 2(3):237-42. PubMed ID: 17410047
[TBL] [Abstract][Full Text] [Related]
6. Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma.
Richards WG; Zellos L; Bueno R; Jaklitsch MT; Jänne PA; Chirieac LR; Yeap BY; Dekkers RJ; Hartigan PM; Capalbo L; Sugarbaker DJ
J Clin Oncol; 2006 Apr; 24(10):1561-7. PubMed ID: 16575008
[TBL] [Abstract][Full Text] [Related]
7. Is malignant pleural mesothelioma a surgical disease? A review of 83 consecutive extra-pleural pneumonectomies.
Trousse DS; Avaro JP; D'Journo XB; Doddoli C; Astoul P; Giudicelli R; Fuentes PA; Thomas PA
Eur J Cardiothorac Surg; 2009 Oct; 36(4):759-63. PubMed ID: 19523843
[TBL] [Abstract][Full Text] [Related]
8. Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients.
Borasio P; Berruti A; Billé A; Lausi P; Levra MG; Giardino R; Ardissone F
Eur J Cardiothorac Surg; 2008 Feb; 33(2):307-13. PubMed ID: 18164622
[TBL] [Abstract][Full Text] [Related]
9. Open lung-sparing surgery for malignant pleural mesothelioma: the benefits of a radical approach within multimodality therapy.
Nakas A; Trousse DS; Martin-Ucar AE; Waller DA
Eur J Cardiothorac Surg; 2008 Oct; 34(4):886-91. PubMed ID: 18656373
[TBL] [Abstract][Full Text] [Related]
10. Malignant pleural mesothelioma: surgical management in 285 patients.
Schipper PH; Nichols FC; Thomse KM; Deschamps C; Cassivi SD; Allen MS; Pairolero PC
Ann Thorac Surg; 2008 Jan; 85(1):257-64; discussion 264. PubMed ID: 18154820
[TBL] [Abstract][Full Text] [Related]
11. Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma.
Neragi-Miandoab S; Richards WG; Sugarbaker DJ
Int J Surg; 2008 Aug; 6(4):293-7. PubMed ID: 18585112
[TBL] [Abstract][Full Text] [Related]
12. Is pleurectomy and decortication superior to palliative care in the treatment of malignant pleural mesothelioma?
Zahid I; Sharif S; Routledge T; Scarci M
Interact Cardiovasc Thorac Surg; 2011 May; 12(5):812-7. PubMed ID: 21345818
[TBL] [Abstract][Full Text] [Related]
13. Improved survival with VATS pleurectomy-decortication in advanced malignant mesothelioma.
Halstead JC; Lim E; Venkateswaran RM; Charman SC; Goddard M; Ritchie AJ
Eur J Surg Oncol; 2005 Apr; 31(3):314-20. PubMed ID: 15780570
[TBL] [Abstract][Full Text] [Related]
14. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.
Flores RM; Pass HI; Seshan VE; Dycoco J; Zakowski M; Carbone M; Bains MS; Rusch VW
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):620-6, 626.e1-3. PubMed ID: 18329481
[TBL] [Abstract][Full Text] [Related]
15. Current concepts in malignant pleural mesothelioma.
Kaufman AJ; Pass HI
Expert Rev Anticancer Ther; 2008 Feb; 8(2):293-303. PubMed ID: 18279069
[TBL] [Abstract][Full Text] [Related]
16. [The clinical picture and therapy of malignant pleural mesothelioma].
Schiebe M; Hoffmann W; Kortmann RD; Bamberg M
Strahlenther Onkol; 1994 Nov; 170(11):628-35. PubMed ID: 7526476
[TBL] [Abstract][Full Text] [Related]
17. Optimal management of malignant mesothelioma after subtotal pleurectomy: revisiting the role of intrapleural chemotherapy and postoperative radiation.
Sauter ER; Langer C; Coia LR; Goldberg M; Keller SM
J Surg Oncol; 1995 Oct; 60(2):100-5. PubMed ID: 7564374
[TBL] [Abstract][Full Text] [Related]
18. Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma.
Lee TT; Everett DL; Shu HK; Jahan TM; Roach M; Speight JL; Cameron RB; Phillips TL; Chan A; Jablons DM
J Thorac Cardiovasc Surg; 2002 Dec; 124(6):1183-9. PubMed ID: 12447185
[TBL] [Abstract][Full Text] [Related]
19. Surgical options in malignant pleural mesothelioma: extrapleural pneumonectomy or pleurectomy/decortication.
Flores RM
Semin Thorac Cardiovasc Surg; 2009; 21(2):149-53. PubMed ID: 19822286
[TBL] [Abstract][Full Text] [Related]
20. Survival after trimodality therapy for malignant pleural mesothelioma: Radical Pleurectomy, chemotherapy with Cisplatin/Pemetrexed and radiotherapy.
Bölükbas S; Manegold C; Eberlein M; Bergmann T; Fisseler-Eckhoff A; Schirren J
Lung Cancer; 2011 Jan; 71(1):75-81. PubMed ID: 19765853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]